Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pan-Asian Clinical Database of EGFR Exon 20 Insertion Mutated Non-small Cell Lung Cancer (NSCLC)

NCT06418412 is registered in ClinicalTrials.gov with National Cancer Centre, Singapore as lead sponsor.

NCT NCT06418412
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06418412 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pan-Asian Clinical Database of EGFR Exon 20 Insertion Mutated Non-small Cell Lung Cancer (NSCLC)
Lead sponsor
National Cancer Centre, Singapore
Phase
Observational
Overall status
Recruiting
Start date
March 15, 2024
Completion date
December 31, 2026
Enrollment
600 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

advanced egfr exon 20 insertion mutated non-small cell lung cancer